leisure time -WSS

leisure time

author：comprehensive 2025-09-27 12:22:52 - browse：37

Without question, the new federal law banning surprise billing is achieving its goal of protecting patients from enormous medical bills. But in doing so, the measure, which was initially projected to lower federal spending, appears to be raising costs elsewhere.

The Biden administration’s new progress report on the process for arbitrating disagreements between insurance companies and providers, which covers the first six months of 2023, shows that in over 80% of payment disputes, the arbiter settled on an amount that was more than the median in-network rate for that service. In other words, insurers were ordered to pay more to an out-of-network provider than they’d pay to a contracted one. Not only that, the sheer volume of disputes means the three federal agencies that run the program are devoting much more time to it than expected.

“It raises concerns for folks that envisioned the arbitration process as helping to moderate costs rather than be a tool these companies can leverage to obtain even higher payments,” said Zachary Baron, the director of Georgetown University’s Health Policy and Law Initiative.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： New details revealed about Purdue's marketing of OxyContin

Wikipedia

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

ProMED sees offers of support, but its future remains unclear

Is there really a nursing shortage in the U.S.?

Trump's false claims about Georgia's 2020 election long debunked

focus

leisure time

focus

Walensky prepares to leave CDC — and Congress — behind

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

In age of alternative facts, a scholarly course on calling out crap

Evacuations in place as 3 wildfires burn in eastern Washington state

Anesthesiologist group: stop taking Ozempic before surgery

Roivant's CEO is a star, but biotech's black hole persists

BioMarin wins approval for gene therapy to treat hemophilia A

Patient advocates sound warning on FDA proposal on salt intake

How one medical school became remarkably diverse

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

hotspot

Roche drug slashes death risk in early

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Eye stem cell transplant could help restore vision in injured people

As Maui death toll rises, number of missing remains unclear

Health tech investors get more selective as pandemic boom fades

Wikipedia

entertainment

hotspot

entertainment